00574.HK
Pa Shun International Holdings Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 0.02
−10.00%Year over year
Reported trailing growth
- Revenue
- -13.8%
- EBITDA
- +551.2%
- EBIT
- +125.5%
- EPS
- +24.4%
- Free cash flow
- +62.9%
- Operating cash flow
- +66.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +6.5%
- EBITDA
- -38.3%
- EBIT
- +172.3%
- Net income
- -3.5%
- EPS
- -2.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025